Carregant...
Novel Antigens for RSV Vaccines
Respiratory syncytial virus (RSV) remains a leading global cause of infant mortality and adult morbidity. Infection, which recurs throughout life, elicits only short-lived immunity. The development of a safe and efficacious vaccine has, thus far, been elusive. Recent technological advances, however,...
Guardat en:
| Publicat a: | Curr Opin Immunol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4553118/ https://ncbi.nlm.nih.gov/pubmed/26070108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2015.04.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|